153 related articles for article (PubMed ID: 22311635)
21. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins.
Tabrizi SJ; Niiro H; Masui M; Yoshimoto G; Iino T; Kikushige Y; Wakasaki T; Baba E; Shimoda S; Miyamoto T; Hara T; Akashi K
J Immunol; 2009 Feb; 182(3):1490-9. PubMed ID: 19155496
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.
Feng B; Cheng S; Hsia CY; King LB; Monroe JG; Liou HC
Cell Immunol; 2004; 232(1-2):9-20. PubMed ID: 15922711
[TBL] [Abstract][Full Text] [Related]
23. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
24. Antigen receptor-mediated signaling pathways in transitional immature B cells.
Kövesdi D; Pászty K; Enyedi A; Kiss E; Matkó J; Ludányi K; Rajnavölgyi E; Sármay G
Cell Signal; 2004 Aug; 16(8):881-9. PubMed ID: 15157667
[TBL] [Abstract][Full Text] [Related]
25. CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes.
Li DH; Tung JW; Tarner IH; Snow AL; Yukinari T; Ngernmaneepothong R; Martinez OM; Parnes JR
J Immunol; 2006 May; 176(9):5321-8. PubMed ID: 16621999
[TBL] [Abstract][Full Text] [Related]
26. IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints.
Granato A; Hayashi EA; Baptista BJ; Bellio M; Nobrega A
J Immunol; 2014 Jun; 192(12):5761-75. PubMed ID: 24835393
[TBL] [Abstract][Full Text] [Related]
27. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW
Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274
[TBL] [Abstract][Full Text] [Related]
28. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.
Swanson BJ; Jäck HM; Lyons GE
Mol Immunol; 1998 Jun; 35(8):445-58. PubMed ID: 9798649
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis.
Xing Y; Igarashi H; Wang X; Sakaguchi N
J Exp Med; 2005 Sep; 202(5):707-19. PubMed ID: 16129705
[TBL] [Abstract][Full Text] [Related]
30. Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells.
Skerjanc IS; Wilton S
FEBS Lett; 2000 Apr; 472(1):53-6. PubMed ID: 10781804
[TBL] [Abstract][Full Text] [Related]
31. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
Ridgeway AG; Wilton S; Skerjanc IS
J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
[TBL] [Abstract][Full Text] [Related]
32. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells.
Enders A; Bouillet P; Puthalakath H; Xu Y; Tarlinton DM; Strasser A
J Exp Med; 2003 Oct; 198(7):1119-26. PubMed ID: 14517273
[TBL] [Abstract][Full Text] [Related]
33. MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.
Kong NR; Davis M; Chai L; Winoto A; Tjian R
PLoS Genet; 2016 Feb; 12(2):e1005845. PubMed ID: 26900922
[TBL] [Abstract][Full Text] [Related]
34. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter.
Rao S; Karray S; Gackstetter ER; Koshland ME
J Biol Chem; 1998 Oct; 273(40):26123-9. PubMed ID: 9748293
[TBL] [Abstract][Full Text] [Related]
35. Myocyte-specific enhancer binding factor 2C expression in fetal mouse brain development.
Leifer D; Li YL; Wehr K
J Mol Neurosci; 1997 Apr; 8(2):131-43. PubMed ID: 9188042
[TBL] [Abstract][Full Text] [Related]
36. B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms.
Antony P; Petro JB; Carlesso G; Shinners NP; Lowe J; Khan WN
Exp Cell Res; 2003 Nov; 291(1):11-24. PubMed ID: 14597404
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
Zhu B; Gulick T
Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
[TBL] [Abstract][Full Text] [Related]
38. ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection.
Adem J; Hämäläinen A; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
Mol Immunol; 2015 Oct; 67(2 Pt B):240-7. PubMed ID: 26054744
[TBL] [Abstract][Full Text] [Related]
39. GCN5 and BCR signalling collaborate to induce pre-mature B cell apoptosis through depletion of ICAD and IAP2 and activation of caspase activities.
Kikuchi H; Nakayama T
Gene; 2008 Aug; 419(1-2):48-55. PubMed ID: 18538956
[TBL] [Abstract][Full Text] [Related]
40. A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering.
Murn J; Mlinaric-Rascan I; Vaigot P; Alibert O; Frouin V; Gidrol X
BMC Genomics; 2009 Jul; 10():323. PubMed ID: 19607732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
